Chiome Bioscience Profit Margin

The latest profit margin for 4583.T is -150.49% as of June 2026. That compares with -129.68% in the prior-year period — down 16.0% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Chiome Bioscience's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4583.T's profit margin moved from -129.68% to -150.49% — a 16.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chiome Bioscience's valuation or profitability profile.

Against Healthcare companies, 4583.T currently prints -150.49% for profit margin, while the sector average sits near 9.48%. That is roughly 1687.3% below the sector mean. Large gaps often invite a closer look at Chiome Bioscience's growth, margins, and balance sheet.

Profit Margin shows how effectively Chiome Bioscience converts resources into returns. At -150.49%, 4583.T may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -129.68% in the prior-year period — down 16.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4583.T's profit margin (-150.49%), review year-over-year change from -129.68%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.